Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Airship AI A | AISP | Oct 18, 2024 | 2.08 | +1.46 |
Akamai Technologies | AKAM | Oct 18, 2024 | 106.67 | +1.85 |
Akanda | AKAN | Oct 18, 2024 | 1.10 | +13.40 |
Akari Therapeutics ADR | AKTX | Oct 18, 2024 | 2.24 | +1.36 |
Akebia Therapeutics | AKBA | Oct 18, 2024 | 1.34 | +0.75 |
Akero Therapeutics | AKRO | Oct 18, 2024 | 31.23 | +1.33 |
Akoustis Technologies | AKTS | Oct 18, 2024 | 0.07 | 0.00 |
Akoya BioSciences | AKYA | Oct 18, 2024 | 3.14 | +2.61 |
Akso Health ADR | AHG | Oct 18, 2024 | 0.94 | +0.37 |
Alamo Group | ALG | Oct 18, 2024 | 177.54 | -1.27 |
Alamos Gold | AGI | Oct 18, 2024 | 20.99 | +4.58 |
Alarm.com | ALRM | Oct 18, 2024 | 53.86 | -0.07 |
Alarum Technologies ADR | ALAR | Oct 18, 2024 | 18.89 | +4.19 |
Alaska Air Group | ALK | Oct 18, 2024 | 44.94 | -1.56 |
Alaunos Therapeutics | TCRT | Oct 18, 2024 | 2.26 | +2.26 |
Albany International | AIN | Oct 18, 2024 | 74.51 | -1.17 |
Albemarle | ALB | Oct 18, 2024 | 95.14 | +0.50 |
Albemarle ADR A Pref | ALB-A | Oct 18, 2024 | 44.75 | -0.86 |
Albertsons Companies A | ACI | Oct 18, 2024 | 19.00 | +3.09 |
Alchemy Investments Acquisition 1 | ALCY | Oct 18, 2024 | 10.91 | 0.00 |
Alchemy Investments Acquisition 1 Units | ALCYU | Oct 18, 2024 | 10.88 | 0.00 |
Alcoa | AA | Oct 18, 2024 | 41.71 | +3.37 |
Alcon | ALC | Oct 18, 2024 | 95.14 | +0.66 |
Aldeyra Therapeutics | ALDX | Oct 18, 2024 | 5.70 | +2.70 |
Alector | ALEC | Oct 18, 2024 | 4.99 | -3.11 |
Alerian Energy Infrastructure E | ENFR | Oct 18, 2024 | 29.61 | +0.24 |
Alerus Financial | ALRS | Oct 18, 2024 | 24.16 | -0.82 |
Alexander & Baldwin | ALEX | Oct 18, 2024 | 18.48 | -0.48 |
Alexanders | ALX | Oct 18, 2024 | 234.80 | +2.19 |
Alexandria Real Estate Equities | ARE | Oct 18, 2024 | 121.79 | +0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.